Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW – Marijuana Production Legalized in Zambia

The Zambian government has approved a proposal seeking to legalize marijuana production in the African country. The marijuana cultivated in Zambia would be strictly used for medicinal purposes and exportation.

Annual license fees for companies looking to operate marijuana businesses in Zambia will be $250,000. Only those whose bids are successful will be awarded commercial permits to grow and export cannabis.

According to the Health Minister Chitalu Chilufya, the government would issue medical marijuana licenses once companies have presented evidence and assurance of their cultivation process to the point where patients can use the end product without inducing the psychoactive effect of adult-use marijuana. This is due to the large number of unsolicited proposals for cultivation licenses for medical marijuana received by the government.

Before legalization, a multi-sectoral team was selected to research the process of marijuana production from the farm to the lab, to the manufacturing plant, and finally to the end consumer who utilizes the products for medicinal purposes. Chilufya further said that the DEC and the Zambia police would be working together to punish people using marijuana illegally.

The Ministry of Health in Zambia would also be tasked with the responsibility of issuing licenses while the Zambia National Service would be strictly supervising the growth of marijuana crops.

The legislation legalizing marijuana production was passed on Wednesday during a cabinet meeting at State House. Several top officials at the Cabinet Office confirmed the passing of the bill, although they could not be identified since they were not allowed to speak to the media.

The unidentified officials further said that the Cabinet Memo seeking for marijuana legalization for medical purposes submitted by the Minister of Health, Dr. Chilufya, was approved by the Cabinet. Interestingly, the Ministry of Home Affairs, Ministry of Agriculture, and the Ministry of Commerce were all working together in an attempt to take over the process of issuing permits from the Health Ministry during the cabinet meeting. The Ministry of Health has been pushing for medical marijuana legalization for some time.

The reason why many Departments were interested in being assigned the responsibility of issuing the licenses is that the whole process was sponsored by wealthy organizations and companies that were initially promised permits, and after the final vote, the Health Ministry won.

Research conducted by The African Cannabis Report revealed that by the year 2023, the legal marijuana industry in Africa could be worth more than $7.1 billion annually. This is the first thorough report on the legal marijuana sector in Africa.

Despite the potential of African marijuana industries, apart from Lesotho, marijuana is prohibited in all the other African countries.

It looks like Zambia is paving the way for Africa to open up to the immense medicinal and economic potential of cannabis, and experts believe that this development is a welcome one to sector players like No Borders Inc. (OTC: NBDR) and IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) who may be quick to see the offshore opportunities opening up.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Florida Lawmakers Continue Debating Edibles and Other Marijuana Issues

The lawmakers in Florida approved the use of marijuana edibles more than two years ago, and this week, the health officials set in motion their plans of making the treats available in retail outlets. The most commonly used marijuana-infused treats by patients and recreational users include cookies, gummies, and lollipops in states that have already legalized the marijuana.

The Department of Health in Florida announced that they developed regulations for products that will be allowed and those that will not be approved; however, they have not released the details.

It will be a while before Floridians can access some edibles such as Space Brownies and Reef Jerky, which are popular among users in other states.

This week the Florida House included edibles in their “parade of horribles” as they continued to voice their opinions about the dangers of adult-use marijuana.

On Wednesday, the presentation made by the House Health Quality Subcommittee was an effort by the chamber to build opposition to the proposed constitutional amendment, which aims at legalizing adult-use marijuana.

“Make It Legal Florida” is the initiative seeking to legalize recreational marijuana in the state, and the bill’s supporters are hoping to include it on the 2020 ballot, but the measure’s timing is not ideal since the marijuana sector in Florida is facing financial upheavals.

Investors are flocking the marijuana industry in Florida with hopes of capitalizing on the emerging lucrative cannabis sector.

Floridians legalized medical marijuana through the ballot in 2016, which led to increased competition. However, intrinsic and extrinsic factors in Florida have led to less bidding for medical marijuana licenses despite the possibility of recreational marijuana legalization.

Trulieve Inc., based in Quincy, was sued for sending customers text messages alerting them about exclusive deals. This violated federal communication laws that prohibit sending of unwanted messages advertising sales of cannabis.

According to the lawsuit, the plaintiffs demanded damages that exceed the $5 million threshold for federal jurisdiction in a class-action trial.

According to Senate President Bill Galvano, the lawmakers are not to address vertical integration systems during the next parliamentary session. Vertical integration critics argue that the system would block out firms that could serve several aspects of the marijuana sector.

Speaking to The News Service of Florida on Thursday, Galvano said that the judiciary is handling the issue. However, lawmakers can still control the issue of psychoactive effects on patients in Florida by limiting the THC concentration in medical cannabis products.

Experts expect the entire marijuana industry, including companies like Hemptown USA and Cannabis Strategic Ventures Inc. (OTCQB: NUGS), to follow the adult-use marijuana legalization debates in the Sunshine State closely since they could have a bearing on events elsewhere in the nation.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Agrify to Provide Financing Option for Customers to Obtain Premium Indoor Grow Products

Agrify, a developer of premium indoor grow solutions, today announced that it is now directly offering a $30 million credit facility for its customers to acquire its premium indoor grow products. The line of credit is accessible for use toward any of the company’s solutions, including commercial grow containers, LED grow lighting, integrated grow systems and racks, vertical farming units, environmental mitigation solutions and more. Together with the company’s recent acquisition of TriGrow Brands and partnership with Valiant America, Agrify can provide turnkey product and installation services and can finance the complete project from start to finish. “We had super strong interest coming out of MJBizCon, and we are prepared to further accelerate and partner with our customers by making this $30 million credit line available to qualified clients on a first-come, first-served basis,” Agrify CEO Raymond Chang stated in the news release. “Given that it is impossible for U.S. cannabis businesses to get traditional bank financing, we want to help our customers deploy more quickly.”

To view the full press release, visit http://cnw.fm/K1cW5

About Agrify

Agrify is a rapidly growing developer of premium indoor grow solutions for the cannabis and hemp marketplace. The company’s comprehensive grow solutions have been developed with one mission in mind: to assist its valued customers in producing the highest quality product possible with consistency and superior yields. Agrify is a non-plant-touching company; to learn more, visit www.Agrify.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – USA CBD Expo Assembles Exciting Lineup of Speakers, Vendors & Brands

USA CBD Expo, the nation’s largest CBD event, is set to take place at the Las Vegas Convention Center (“LVCC”) February 13-15, 2020. The three-day gathering is anticipated to feature over 40 expert speakers, 300 vendors and 500 brands. Topics covered at the CBD event will include health and fitness, investing, regulations, product development and agriculture. Speakers at the event include renowned CBD & hemp industry players such as Mike Lewis, co-founder of Third Wave farms; Matt Hagan, owner of TruHarvest Farms; Dara Torres, Olympic champion; Kyle Turley, retired NFL football player; and Shayna Taylor, owner of Bottle and Stone. In addition to the exciting list of speakers, USA CBD Expo also assembles the industry’s biggest and best exhibitors. Participants can expect to see new and innovative CBD and hemp products including edibles, beverages, cosmetics and even pet products.

To view the full press release, visit http://cnw.fm/FTXg3

About USA CBD Expo

The Nation’s Largest CBD Event is coming to Vegas! USA CBD Expo succeeds in concentrating the entire CBD and Hemp industry into one comprehensive, all-inclusive event. USA CBD Expo Vegas features 300+ vendors and 500+ of the industry’s best brands. Sample thousands of the newest and most innovative CBD products including edibles, tinctures, vapeables, beverages, topicals, cosmetics, and pet products. Learn from 40+ expert speakers about all aspects of CBD and Hemp! For more information, visit www.USACBDExpo.com and www.Events.American-TradeShow.com/USACBDExpovegas.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Terminates Proposed Business Combination to Focus on Rapidly Expanding CBD & MSO Businesses

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) this morning reported the termination of its proposed business combination as the market adapts to the shifting macro environment. Green Growth Brands has agreed to repay the advance of $5 million by January 31, 2020 and to reimburse Moxie $4 million in deal fees on or before July 1, 2020, with both payments to be made in cash. There is no break fee to be paid in connection with the termination. The company plans to continue its aggressive growth strategy in both the MSO and CBD businesses. Green Growth’s MSO business currently includes a 47-dispensary rollout in three key states. The company intends to continue its expansion in this line of business, opening the remaining 45 dispensaries. “We are aggressively growing our businesses across America as we drive to become a leading cannabis retailer in the country,” Green Growth Brands CEO Peter Horvath stated in the news release. “While we continue to be open to collaborating with other industry leaders, we need to ensure we are focused on building our operational strengths, maximize our returns and, most importantly, avoiding excessive dilution to our shareholder base.”

To view the full press release, visit http://cnw.fm/Vv88L

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. GGB is expanding its cannabis operations throughout the U.S., via dispensaries in Nevada, Massachusetts and Florida and the largest network of CBD shops in malls across the country and ShopSeventhSense.com. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGBXF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) Enters MOU to Complete Cannabis Cultivation Facility Buildout

Isracann Biosciences (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF), an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, on Tuesday announced its entrance into a memorandum of understanding (“MOU”) for a joint venture (“JV”) with a late stage cannabis farm in Israel. The JV is intended to complete a late stage buildout of a cannabis cultivation facility in an agricultural center proximal to several licensed producers (“LP’s”) west of Be’er Sheva, Israel (the “Be’er Sheva Farm”). Pursuant to the JV, Isracann will capitalize the buildout of the remaining construction in exchange for an economic interest in the project in compliance with Israeli laws. Following the signing of a definitive agreement, which is subject to continued due diligence of the Be’er Sheva Farm by Isracann, the terms of the joint venture will be released. “We’ve been evaluating several opportunities to expedite our commercialization plans and based on my inspection of the property this farm offers the ability to shorten our time-to-market. The fundamentals are already in place, including building permits, and the basic infrastructure is already constructed which accelerates timing. Once we conclude our due diligence efforts, the proposed plan will be to advance the technical efforts including completion of the greenhouse and concurrently implementing a project characterization strategy in preparation to planting. There is still a lot of work to complete, but our efforts at our Nir Israel farm have already provided us with regional business relationships, experienced advisors, and extensive preparations that we can readily extend and implement across both locations,” Isracann VP Operations Matt Chatterton stated in the news release.

To view the full press release, visit http://cnw.fm/1IIlb

About Isracann Biosciences Inc.

Isracann is an Israeli-based cannabis company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied, major European marketplaces. Based in Israel’s agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research. The company has secured agreements within Israel for medicinal marijuana cultivation. For more information, visit the company’s website at www.Isracann.com.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expands Distribution to New Markets

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced expansion of Canadian distribution to all ten provinces, with select brands to be available in Québec and Newfoundland and Labrador. According to the update, Supreme Cannabis entered into a letter of intent with Société Québécoise du Cannabis (“SQDC”) to supply 7ACRES products to retail stores across Québec. The company, on November 21, 2019, also entered into a formal agreement to supply the Newfoundland and Labrador Liquor Corporation (“NLC”) with 7ACRES high-end cultivars. “With increased packaging capacity we are pleased to have the recreational supply necessary to serve new consumers in Québec and Newfoundland and Labrador. As we enter two new provinces, we continue to benefit from the strength of our experienced sales team,” Supreme Cannabis CEO Navdeep Dhaliwal said in the news release. “In anticipation of our 7ACRES brand entering these priority provinces, we specifically launched strains with east coast consumers in mind.”

To view the full press release, visit http://cnw.fm/Qv8ec

About Supreme Cannabis Company

The Supreme Cannabis Company, Inc., is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the company has emerged as one of the world’s fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products. Supreme Cannabis’ portfolio includes 7ACRES, its wholly-owned subsidiary and multi-award-winning brand; Blissco, a wellness cannabis brand and a multi-licensed processor and distributor based in British Columbia; Truverra Inc., a global medicinal cannabis brand and licensed cultivator; Sugarleaf by 7AC, crafted for the convenient pleasure of the cannabis experience; Cambium Plant Sciences, a plant genetics and cultivation IP company; Medigrow Lesotho, an cannabis oil producer located in southern Africa; Supreme Heights, an investment platform focused on CBD brands in the UK and Europe and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada. Supreme trades as FIRE on the Toronto Stock Exchange (TSX: FIRE), SPRWF on the OTC Exchange in the United States (OTCQX: SPRWF) and 53S1 on the Frankfurt Stock Exchange (FRA: 53S1). Follow the company on Instagram, Twitter, Facebook and YouTube. For more information, visit the company’s website at www.Supreme.ca.

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://cnw.fm/FIRE

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Prices $5.58M Series D Cumulative Redeemable Perpetual Preferred Stock Offering

Youngevity International (NASDAQ: YGYI, YGYIP), a leading multi-channel lifestyle company, today announced the pricing of its underwritten public offering of 245,398 shares of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock at a price to the public of $22.75 per share. Youngevity expects approximately $5.58 million in gross proceeds from the offering, from which it intends to use the net proceeds for working capital and other general corporate purposes. The closing of the offering, subject to the satisfaction of customary conditions, is expected to occur on or about December 20, 2019. The shares of Series D Preferred Stock trade on the Nasdaq Capital Market under the symbol “YGYIP” and will not be convertible into or exchangeable for any of the company’s other securities. The Benchmark Company, LLC is acting as sole book-running manager of the offering.

To view the full press release, visit http://cnw.fm/SAyZ4

About Youngevity International, Inc.

Youngevity International, Inc. (NASDAQ: YGYI, YGYIP), is a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise. The company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity. YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For investor information, please visit www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – MLB Action Prompts Stakeholders to Expect a Marijuana Policy Shift in the NFL

Toward the end of last week, a top National Football League (NFL) team owner, Jerry Jones, and the New England Patriots quarterback player, Tom Brady, said that the league’s marijuana rules are bound to change after the MLB announced that it is eliminating marijuana from the list of banned substances for baseball players.

In an on-air interview with a Dallas radio station on Friday, Jones said that any issue regarding marijuana is a sensitive topic across the globe. He also noted that the leagues are excited about the possibility of being at par with the social and legal scene on marijuana.

Jones observed that they are not only looking at the issue of competitiveness when it comes to substance usage but also the law, as well as the societal focus on marijuana. It is also an important issue to discuss with the players.

In an on-air interview with Westwood One Sports on Thursday, Brady said that the MLB move to remove marijuana is a sign that times are changing, and progress is good.

Brady further said that there has been rumors that the NFL is going to follow in the MLB’s footsteps. He noted that the stigma against marijuana is being eradicated. Brady also added that he is hoping that before a decision is made, they will research the benefits that will ensue from the move.

Currently, the NFL teams and players associations are negotiating on a collective bargaining agreement; this will give the owners a chance to change the rules on drug testing and punishment.

Brady said that he does not know much about the issue, but he is sure there are experts present to provide them with advice.

Jones has always been against the NFL’s strict stance on marijuana. A recent survey on cannabis showed that 67% of Americans are in favor of marijuana legalization. Punishing players for consuming cannabis could be more harmful to the NFL public image than do any good.

In the annual drugs test, if an NFL player’s results are positive, several fines are imposed, suspension and rehabilitation, whereas a contracted player can be tested at a minimum notice of 3 hours. In 2018, the NFL collected $4,000,000 in fines due to positive drug tests.

Speaking to Los Angeles Times, the former Chargers offensive lineman Kyle Turley said that players are known to side-step the process, passing annual marijuana tests, and then smoking weed the rest of the year. Baseball is a brutal game, and marijuana could help other players as it saved his life.

Speaking to The Washington Post in October, sources close to league owners said that the owners are willing to amend marijuana policies by making them less punitive, and this would limit NFL Commissioner Roger Goodell’s disciplinary powers over cannabis. The league and union are willing to study how pot can be used to manage pain.

Currently, the NFL team owners and NFL players’ unions are negotiating, and neither of the parties can comment on their progress. Past agreement negotiations lasted for a period of 57 days.

According to experts, this possible policy shift is likely to be good news for cannabis industry players like Neutra Corp. (OTC: NTRR) and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) who have always wanted all categories of people to enjoy the benefits of marijuana, especially for medicinal purposes.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Senators Pressure DEA to Provide Update on Cannabis Grower Applications

Top federal drug and health agencies are under pressure from a group of senators to provide an update about the long overdue increase in the number of authorized marijuana manufacturers for study purposes.

Led by Senator Elizabeth Warren (D-MA), the lawmakers wrote a letter emphasizing the importance of expanding the supply of research-grade marijuana as more states move to legalize marijuana either for recreational or medical consumption. The letter was addressed to the Drug Enforcement Administration (DEA), Office of National Drug Control Policy, and the Department of Health and Human Services.

Although the DEA announced that it would approve additional marijuana growers for research-grade weed more than three years ago, it is yet to deliver on its promise since it keeps delaying the process. In August the agency said that it is in the process of approving the applications; however, due to the large number of applications, it will have to establish alternative rules before issuing new permits.

The DEA made that announcement before the deadline issued by the court previously, which required the agency to take action. The lawsuit against the DEA was filed by a researcher whose application for marijuana production for research purposes had been suspended. The court dismissed the suit in October since the agency provided an update.

However, the senators were not placated by the agency’s response, and they are seeking guidance on the process to be taken to ensure that the qualified researchers are granted licenses on time.

The letter which was sent on Wednesday last week said that the number of studies covering the therapeutic effects of cannabis is limited even though millions of U.S. citizens are legally permitted to consume medical or recreational marijuana. The letter further noted that the number of Americans seeking doctors’ advice on marijuana treatment for ailments, such as chronic pain, PTSD, or terminal illnesses is ever-growing; therefore, federal agencies should make an effort to increase the amount of credible information on marijuana health benefits and health risks.

Being classified under Schedule 1 of the Controlled Substances Act creates a barrier for researchers to conduct studies on marijuana.

The lawmakers also argued in the letter that inhibiting research opportunities and discouraging researchers who are independent and qualified from conducting studies on the benefits of marijuana is a hindrance to states looking to implement their marijuana laws. Marijuana studies are vital to developing an understanding of marijuana, and the findings would be a gem to the doctors, patients, and lawmakers across the U.S.

The letter also poses five questions to the agencies, and they expected the response by January 10.

The status and timeline of application approval by the DEA
Information about the existing supply of research-grade marijuana and if the facility is cultivating more varieties.
Information on whether the government would reschedule marijuana
The application process guidelines.
Their support for research on the therapeutic effects of marijuana

The senators also wrote that there is a need for evidence-based public policy, which is vital to securing the health of the citizens since millions of Americans can now access medical and recreational marijuana. They added that the federal government should provide the necessary leadership and tools required in developing research in cannabis.

Other senators who signed the letter include Ron Wyden (D-OR), Kristen Gillibrand (D-NY), Cory Booker (D-NJ), Ed Markey (D-MA), and Jacky Rosen (D-NV).

To what extent will such letters result in tangible results on the regulatory front? Experts cannot be certain that marijuana companies like Dama Financial and Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) are still keeping count of the different letters that have been written to the federal authorities on matters of marijuana policy reform since the feds seem to be working based on their own schedule.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.